Renal bone disease 1990: an unmet challenge for the nephrologist (Q37953234)

25 August 2017

1 reference

title

Renal bone disease 1990: an unmet challenge for the nephrologist (English)

1 reference

25 August 2017

1 reference

H Malluche

1

1 reference

25 August 2017

M C Faugere

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 August 1990

1 reference

25 August 2017

1 reference

25 August 2017

38

1 reference

25 August 2017

193-211

1 reference

25 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1990.187

25 August 2017

0 references

cites work

The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part I of IV parts: mechanisms of calcium transfer between blood and bone and their cellular basis: morphological a

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Measurements of gamma-carboxyglutamate and circulating osteocalcin in normal children and adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Osteonectin, a bone-specific protein linking mineral to collagen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

In vitro model of aluminum-induced osteomalacia: Inhibition of hydroxyapatite formation and growth

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Tetracycline-based histological analysis of bone remodeling

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

A hypothetical mechanism for the stimulation of osteonal remodelling by fatigue damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Bone Resorption Restored in Osteopetrotic Mice by Transplants of Normal Bone Marrow and Spleen Cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

On the mechanisms of bone resorption. The action of parathyroid hormone on the excretion and synthesis of lysosomal enzymes and on the extracellular release of acid by bone cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Inhibition of bone resorption by acetazolamide in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Role of carbonic anhydrase in bone resorption induced by 1,25 dihydroxyvitamin D3 in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Parathyroid hormone stimulates bone resorption via a Na–Ca exchange mechanism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Morphological evidence of gap junctions between bone cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1990.187

1 reference

7 January 2021

Role of osteoblasts in hormonal control of bone resorption—A hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Protamine: a powerful in vivo inhibitor of bone resorption

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The macrophage as an effector cell

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Circadian rhythms of blood minerals in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Diurnal variation of serum calcium and phosphorus in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Diurnal variations of plasma calcium and calcitonin function in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Daily fluctuations in plasma calcium, phosphate, and their radionuclide concentrations in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

A physiological view of in vivo calcium dynamics: the regulation of a nonlinear self-organized system

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Plasma calcium control at quiescent bone surfaces: a new approach to the homeostatic function of bone lining cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Vitamin D: Metabolism and Biological Actions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Calcitonin: physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

In vitro evidence that local and systemic skeletal effectors can regulate 3[H]-thymidine incorporation in chick calvarial cell cultures and modulate the stimulatory actions(s) of embryonic chick bone extract

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Immunocytochemical evidence for endogenous calcitonin and parathyroid hormone in osteoblasts from the calvaria of neonatal mice. Absence of endogenous estradiol and estradiol receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Bone histology in incipient and advanced renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Influence of Vitamin D3, 1,25-Dihydroxyvitamin D3, and 24,25-Dihydroxyvitamin D3on Parathyroid Hormone Secretion, Adenosine 3 ′,5′-Monophosphate Release, and Ultrastructure of Parathyroid Glands in Organ Culture*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The Acute Effects of 1,25-Dihydroxycholecalciferol on Serum Immunoreactive Parathyroid Hormone in the Dog*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Suppressive effect of 1,25-dihydroxyvitamin D3 on circulating parathyroid hormone in acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Control of 25-hydroxycholecalciferol metabolism by parathyroid glands

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Basic and clinical concepts related to vitamin D metabolism and action (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Plasma levels of vitamin D metabolites in renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Intestinal absorption of calcium and the effect of renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Study of intestinal absorption of calcium in patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Impaired Parathyroid Hormone Metabolism in Patients with Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Synovial amyloidosis in patients undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Metabolic Bone Disease in Patients on Maintenance Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Hemodialysis-associated platelet activation and thrombocytopenia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Abnormal vitamin-D levels

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Infant formula as a cause of aluminium toxicity in neonatal uraemia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Skeletal Resistance to Endogenous Parathyroid Hormone in Patients with Early Renal Failure. A Possible Cause for Secondary Hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Bone mass in maintenance haemodialysis. Prospective study with sequential biopsies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Stainable aluminum and not aluminum content reflects bone histology in dialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Suppression of parathyroid hormone secretion by aluminum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of aluminum and parathyroid hormone on osteoblasts and bone mineralization in chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Bone aluminum and histomorphometric features of renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Bone ultrastructure and x-ray microanalysis of aluminum-intoxicated hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Aluminum absorption and distribution: effect of parathyroid hormone.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Aluminum and osteomalacia after parathyroidectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Parathyroid hormone-mediated aluminum deposition and egress in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Aluminum associated bone disease: clinico-pathologic correlation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Osteomalacia after parathyroidectomy in patients with uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The case against aluminum affecting parathyroid function.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Oral aluminum administration to uremic, hyperparathyroid, or vitamin D-supplemented rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

1,25(OH)2D3 receptors and endorgan response in experimental aluminium intoxication.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Interactions between aluminum and the actions and metabolism of vitamin D3 in the chick

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

In vitro effects of aluminum on bone phosphatases: a possible interaction with bPTH and vitamin D3 metabolites

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Noncompetitive inhibition by aluminum, scandium and yttrium of acetylcholinesterase from Electrophorus electricus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Continuous ambulatory peritoneal dialysis and bone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Acute aluminium intoxication in patients on continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Amyloid syndromes associated with hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effects of vitamin D and parathyroid hormone on muscle: potential role in uremic myopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.1990.187

1 reference

7 January 2021

Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

A sensitive bioassay of parathyroid hormone in plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Cytochemical bioassay of parathyroid hormone: characteristics of the assay and analysis of circulating hormonal forms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Endogenous Biologically Active Human Parathyroid Hormone: Measurement by a Guanyl Nucleotide-Amplified Renal Adenylate Cyclase Assay*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Plasma 25-Hydroxycholecalciferol in Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Detection and distribution of aluminium in bone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

A program package for quantitative analysis of histologic structure and remodeling dynamics of bone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of the time of administration of calcium acetate on phosphorus binding.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Role of phosphate depletion and high dialysate calcium in controlling dialytic renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Impairment of renal function in patients on 1alpha-hydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Vitamin-D analogues and renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Low dose calcitriol versus placebo in patients with predialysis chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Pharmacological parathyroidectomy by oral 1,25(OH)2D3 pulse therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Oral calcitriol and calcium: efficient therapy for uremic hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The effects of intraperitoneal calcitriol on calcium and parathyroid hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Parenteral calcitriol for treatment of severe renal osteodystrophy in children with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Unique effects of 24,25-dihydroxyvitamin D3 in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of vitamin D metabolites on calcitriol metabolism in experimental renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Propranolol therapy for secondary hyperparathyroidism in uraemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Reduction by cimetidine of serum parathyroid hormone levels in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Desferrioxamine, aluminium, and dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Serum concentration and peritoneal transfer of aluminum during treatment by continuous ambulatory peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Mucormycosis: association with deferoxamine therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Deferoxamine does not increase the risk for bacteremia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of deferoxamine mesylate on the growth of mucorales

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Efficacy of intramuscular and intraperitoneal deferoxamine for aluminum chelation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

[Some topical problems of subtotal parathyroidectomy in patients on haemodialysis]

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Elective total parathyroidectomy without autotransplant in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Nonsurgical treatment of primary hyperparathyroidism with sonographically guided percutaneous injection of ethanol: results in a selected series of patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Results of subtotal parathyroidectomy in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1990.187

7 January 2021

Identifiers

DOI

10.1038/KI.1990.187

1 reference

release_d4ndaikqkba2zim3fvxdnn75b4

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d4ndaikqkba2zim3fvxdnn75b4

24 November 2022

mapped directly with Wikidata item

1 reference